SARAH ADAMS: Open Payments
NPI 1568559383 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,414 in 148 payments from 24 companies in 2025. Trend: 2023 $2,429 · 2024 $4,803 · 2025 $3,414
Food & beverage: $3,019Education: $395
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $588 |
| GlaxoSmithKline, LLC. | 37 | $560 |
| Actelion Pharmaceuticals US, Inc. | 9 | $316 |
| Inspire Medical Systems, Inc. | 7 | $302 |
| Regeneron Healthcare Solutions, Inc. | 11 | $272 |
| Verona Pharma, Inc. | 18 | $240 |
| JAZZ PHARMACEUTICALS INC. | 3 | $149 |
| Amgen Inc. | 10 | $141 |
| GENZYME CORPORATION | 4 | $108 |
| Insmed, Inc. | 4 | $96 |
Products named: NUCALA, DUPIXENT, TEZSPIRE, INSPIRE, OPSUMIT, Ohtuvayre, FASENRA, XYWAV.
Industry payments across MI — which companies pay providers there.
